|
Nov 29
|
Longboard Pharmaceuticals Announces Initiation of First-in-Human Phase 1 Clinical Study of LP659 in Adult Healthy Volunteers
|
|
Aug 10
|
Institutional investors own a significant stake of 39% in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)
|
|
Aug 3
|
Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial Results
|